Nitric oxide in sepsis-syndrome: Potential treatment of septic shock by nitric oxide synthase antagonists

Kidney International, Supplement

Volumn 53, Issue 64, 1998, Pages

  Ketteler, M ^a   Cetto, C ^a   Kirdorf, M ^a   Jeschke, G S ^a   Schafer, J H ^a   Distler, A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cytotoxicity; Hypotension and NO; Nitric oxide; Sepsis syndrome; Vasodilation

Indexed keywords

ALPHA INTERMEDIN; ARGININE; CYCLIC GMP; CYTOKINE; ENDOTOXIN; EXOTOXIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN;

CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; CYTOTOXICITY; DRUG TARGETING; HEART INDEX; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; VASODILATATION; ANIMAL; DRUG ANTAGONISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; ENZYME INHIBITORS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0031882444     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)